Specialized Nerve Stimulation Systems for High-Risk Environments

Publication ID: 24-11857788_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Nerve Stimulation Systems for High-Risk Environments,” Published Technical Disclosure No. 24-11857788_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857788_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,788.

Summary of the Inventive Concept

This inventive concept adapts the original coordinated trigeminal and vagal nerve stimulation method for reducing bleeding in specific, high-risk environments, such as high-altitude, disaster relief, extreme weather, and high-security settings, ensuring tailored solutions for unique operational needs.

Background and Problem Solved

The original patent disclosed a method and apparatus for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the original design may not be suitable for extreme environments, where additional considerations, such as low oxygen levels, waterproofing, and enhanced security, are crucial. This inventive concept addresses these limitations by introducing specialized variations and niche solutions for high-risk environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of systems and methods that adapt the original coordinated nerve stimulation approach to specific high-risk environments. For instance, a system for reducing bleeding in high-altitude environments features a portable apparatus adapted to operate at low oxygen levels and extreme temperatures. Another embodiment includes a waterproof apparatus with GPS tracking for treating bleeding in patients during natural disasters. Other variations include a wearable device with a sensor for monitoring blood coagulation levels in patients with bleeding disorders, an apparatus with enhanced security features for high-security facilities, and a ruggedized apparatus for treating bleeding in extreme weather environments.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original coordinated nerve stimulation method, tailored to specific high-risk environments. These adaptations, such as low-oxygen operation, waterproofing, and enhanced security, are non-obvious and provide a significant inventive step over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include, but are not limited to, systems for reducing bleeding in patients with specific medical conditions, such as hemophilia, or in patients undergoing surgery in remote or resource-constrained areas. Other variations could include adapting the apparatus for use in space exploration or in areas with limited access to medical resources.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including emergency response, disaster relief, high-security facilities, and extreme environment exploration. The market for these specialized nerve stimulation systems is expected to grow as the need for tailored solutions in high-risk environments increases.

Field of Art

Biomedical electrical stimulation and nerve modulation technologies, focusing on non-invasive therapeutic interventions for physiological processes such as hemostasis and bleeding control

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in neurostimulation, electrical medical devices, and physiological response mechanisms, possessing knowledge of nerve stimulation techniques and environmental adaptation strategies for medical technologies

Obviousness Rationale

A person having ordinary skill in the art would recognize that the source patent's core method of coordinated trigeminal and vagal nerve stimulation for bleeding control represents a fundamental technique that can be readily adapted to various environmental and operational contexts. The PTD's variations represent predictable extensions of the original patent's core technological concept, applying known design modification principles to expand the utility of the nerve stimulation approach across different use scenarios.

Obvious Combinations & Variations

Source Patent Element
Non-invasive electrical stimulation system targeting trigeminal and vagal nerves
PTD Variation
Adaptation of the stimulation system for high-altitude, low-oxygen environments with temperature resistance
Obviousness Reasoning
A PHOSITA would recognize that environmental adaptation involves predictable engineering modifications such as component selection and thermal/pressure compensation, which are standard design practices in medical device development
Source Patent Element
Wireless communication circuitry for device control
PTD Variation
Integration of GPS tracking and enhanced security features like biometric authentication
Obviousness Reasoning
Adding location tracking and security mechanisms represents a known technique for expanding device functionality using standard communication and authentication technologies
Source Patent Element
Electrical stimulation apparatus worn on head/neck region
PTD Variation
Waterproof and ruggedized device design for disaster relief and extreme weather applications
Obviousness Reasoning
Modifying device enclosure to improve environmental resistance is a predictable solution using established materials science and engineering design principles
Source Patent Element
Periodic electrical stimulation method
PTD Variation
Adding sensor-based blood coagulation monitoring to dynamically adjust stimulation parameters
Obviousness Reasoning
Incorporating real-time physiological monitoring represents an obvious enhancement using known biomedical sensing and feedback control techniques
Source Patent Element
Nerve stimulation for bleeding reduction
PTD Variation
Specialized configurations for specific medical conditions like hemophilia or surgical interventions
Obviousness Reasoning
Tailoring medical device configurations for specific patient populations is a standard design approach involving predictable modifications to existing therapeutic methods
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857788, the present publication demonstrates that the claimed variations in nerve stimulation systems represent obvious extensions of the prior art, wherein a person having ordinary skill in the art would readily conceive of adapting the fundamental nerve stimulation method to diverse environmental and operational contexts through predictable engineering modifications.

Original Patent Information

Patent NumberUS 11,857,788
TitleMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Assignee(s)THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH